Equities

Integra Lifesciences Holdings Corp

Integra Lifesciences Holdings Corp

Actions
  • Price (EUR)22.40
  • Today's Change0.000 / 0.00%
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Nov 13 2024 18:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue1,5421,5581,542
OPERATING EXPENSES
Cost of revenue total569576565
Selling, general and admin. expenses, total603596606
Depreciation/amortization121417
Unusual expense(income)1615845
Other operating expenses, total------
Total operating expense1,4311,3221,309
Operating income111235233
Other, net4.581625
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes81214215
Provision for income taxes133346
Net income after taxes68181169
Minority interest------
Net income before extra. Items68181169
Total extraordinary items------
Net income68181169
Inc.avail. to common excl. extra. Items68181169
Inc.avail. to common incl. extra. Items68181169
EPS RECONCILIATION
Basic/primary weighted average shares808385
Basic/primary eps excl. extra items0.852.182.00
Basic/primary eps incl. extra items0.852.182.00
Dilution adjustment------
Diluted weighted average shares808485
Diluted eps excl. extra items0.842.161.98
Diluted eps incl. extra items0.842.161.98
COMMON STOCK DIVIDENDS
DPS - common stock primary issue------
Gross dividend - common stock000
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental515050
SUPPLEMENTAL INCOME
Depreciation, supplemental414039
Total special items1615845
NORMALISED INCOME
Normalized income before taxes242272259
Effect of special items on income taxes269.009.48
Income tax excluding impact of special items404255
Normalized income after tax202229204
Normalized income avail. to common202229204
Basic normalized EPS2.532.762.41
Diluted normalized EPS2.522.752.39
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.